A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic Hepatitis
To access this article, please choose from the options below
Supported by the NIH (R01 AA013933 to V.S.), the NIH funded Mayo Clinical Research Unit (CTSA), and Amgen (to V.S.), which provided study drug and partially defrayed costs for cytokine analyses that exceeded the NIH budget.
The authors disclose the following: All analyses and writing were conducted at the Mayo Clinic. Authors have no other conflicts of interest to disclose.
PII: S0016-5085(08)01669-7
doi:10.1053/j.gastro.2008.08.057
© 2008 AGA Institute. Published by Elsevier Inc. All rights reserved.

